Long-term Benefits of Treatment with Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
CONCLUSION: This study suggested that long-term administration of tolvaptan may improve renal function and inhibit total kidney volume growth.PMID:34526469 | DOI:10.1272/jnms.JNMS.2022_89-303
Source: Journal of Nippon Medical School - Category: Universities & Medical Training Authors: Naoko Shimoda Mariko Ikeda Tomohiro Yan Sayuri Kawasaki Akio Hirama Tetsuya Kashiwagi Yukinao Sakai Source Type: research
More News: Clinical Trials | Polycystic Kidney Disease | Sodium | Study | Universities & Medical Training | Urology & Nephrology